GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to chinadaily ...

United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

MSD's Gardasil 9, which is India's first gender-neutral HPV vaccine, is also available. The 9-valent HPV vaccine targets sub-types 6, 11, 16, 18, 31, 33, 45, 52 and 58 among Indian girls and women ...

LEGAZPI CITY — A magnitude 3.9 earthquake hit Masbate on Sunday morning, April 13, which followed a minor tectonic movement also felt in the island province on Saturday. The Philippine Institute ...

products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed the market last year because Keytruda, its biggest moneymaker, could face ...

Following the announcement, MRK stock fell over 9% on February 5. To conclude, the defendants allegedly misled investors by overstating sales expectations for Gardasil in China, despite sluggish ...

MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.

MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.

The vaccine, known as Gardasil, has been given to millions of ... Currently, CDC recommendations already suggest adolescents aged 9 to 14 get two doses. Three doses are recommended for teens ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) under new HHS Secretary Robert F. Kennedy Jr., experts looked poised to ...

Gardasil/Gardasil 9 shot up 59% to $1.5 billion on a bounce back in demand as COVID-19 restrictions eased and strong uptake in China.